All companies
Visit website
Eyedaptic
OperatingEyedaptic, Inc.
Healthcare · Founded 2016
Augmented Reality Glasses for Vision Loss
Post-money valuation ⓘ
$12.7M
As of Oct 2021 · from Eyedaptic Stock 1 · pre-money + amount raised, not a traded price
Total raised
$665,255
Across 1 round since 2021
Latest share price
$0.80
Eyedaptic Stock 1 offering price
Financials
FY2018–FY2023 · from SEC filings · hover any figure for its source$0
−$796K
2018
$6K
−$796K
2019
$62K
−$654K
2020
$205K
−$717K
2021
$212K
−$677K
2022
$458K
−$687K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
Income statement
Revenue
$0
$5,580
$62,313
$204,568
$212,230
$458,408
Cost of goods sold
$0
$4,522
$38,398
$113,550
$88,219
$203,358
Gross margin
—
19%
38%
44%
58%
56%
Net income
-$795,652
-$795,652
-$653,856
-$716,558
-$676,833
-$686,966
Taxes paid
$0
$0
$0
$0
$800
$800
Balance sheet
Cash
$450,608
$450,608
$363,254
$399,021
$508,134
$713,355
Accounts receivable
$0
$0
$0
$0
$0
$0
Total assets
$450,608
$450,608
$379,118
$465,768
$671,604
$883,555
Short-term debt
$23,510
$23,510
$234,368
$1,278,001
$1,614,132
$1,721,468
Long-term debt
$625,000
$625,000
$971,319
$147,000
$675,000
$1,255,000
Total liabilities
$648,510
$648,510
$853,457
$1,425,001
$2,289,132
$2,976,468
Other
Headcount
—
3
3
3
4
3
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$12.7M
post-money
Eyedaptic Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $665.3K / $1.1MInvestors 653Post-money $12.7M
Reg CF annual-report compliance
Not required3+ reports filed & assets ≤ $10M
Filed 4 of 6 annual reports (FY2020–FY2025)
653 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 18 filings on EDGARSource: ManualCIK 0001713933Share price $0.80
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.